RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-8.89%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$3.57B
AUM Growth
+$3.57B
(-15%)
Cap. Flow
+$230K
Cap. Flow
% of AUM
0.01%
Top 10 Holdings %
Top 10 Hldgs %
48.82%
Holding
78
New
14
Increased
15
Reduced
33
Closed
9
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$75.7M |
| 2 |
Merck
MRK
|
$60.7M |
| 3 |
Beam Therapeutics
BEAM
|
$60.5M |
| 4 |
ONEM
1Life Healthcare, Inc. Common Stock
ONEM
|
$56.7M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$52.7M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$116M |
| 2 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
$109M |
| 3 |
Boston Scientific
BSX
|
$73.8M |
| 4 |
Centene
CNC
|
$43.3M |
| 5 |
HCA Healthcare
HCA
|
$42.2M |
Sector Composition
| 1 | Healthcare | 97.84% |
| 2 | Industrials | 0.87% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCDA
26
DELISTED
Tricida, Inc. Common Stock
TCDA
| $46.8M | 1.31% |
2,126,600
-2,500
| -0.1% | -$55K |
|
27
Neurogene
NGNE
$280M
| $46M | 1.29% |
4,041,211
+2,120,380
| +110% | +$24.1M |
|
28
Krystal Biotech
KRYS
$4.34B
| $45.5M | 1.28% |
1,051,800
-38,400
| -4% | -$1.66M |
|
29
Atara Biotherapeutics
ATRA
$88M
| $45M | 1.26% |
5,293,370
+644,800
| +14% | +$5.49M |
|
|
AXNX
30
DELISTED
Axonics, Inc. Common Stock
AXNX
| $38.3M | 1.07% |
1,507,400
-24,600
| -2% | -$625K |
|
|
PRAH
31
DELISTED
PRA Health Sciences, Inc.
PRAH
| $36.8M | 1.03% |
442,700
-7,100
| -2% | -$590K |
|
32
Scholar Rock
SRRK
$3.29B
| $35M | 0.98% |
2,890,089
-50,800
| -2% | -$615K |
|
33
DexCom
DXCM
$30.8B
| $34.8M | 0.98% |
+129,300
| New | +$34.8M |
|
|
EIDX
34
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $33.8M | 0.95% |
689,478
-11,700
| -2% | -$573K |
|
35
Genmab
GMAB
$16.6B
| $32.8M | 0.92% |
1,549,000
+612,300
| +65% | +$13M |
|
|
AMED
36
DELISTED
Amedisys
AMED
| $32.6M | 0.91% |
177,565
-3,500
| -2% | -$642K |
|
37
CryoPort
CYRX
$423M
| $31M | 0.87% |
1,817,663
+975,300
| +116% | +$16.6M |
|
38
Zymeworks
ZYME
$1.06B
| $30.8M | 0.86% |
+868,600
| New | +$30.8M |
|
39
Replimune Group
REPL
$459M
| $29.7M | 0.83% |
2,980,493
+214,086
| +8% | +$2.13M |
|
40
Wave Life Sciences
WVE
$1.25B
| $27.4M | 0.77% |
2,927,352
-399,141
| -12% | -$3.74M |
|
|
CTLT
41
DELISTED
CATALENT, INC.
CTLT
| $26.3M | 0.74% |
+506,300
| New | +$26.3M |
|
|
PPD
42
DELISTED
PPD, Inc. Common Stock
PPD
| $23M | 0.64% |
+1,290,832
| New | +$23M |
|
43
Ardelyx
ARDX
$1.56B
| $22.2M | 0.62% |
3,904,100
-95,900
| -2% | -$545K |
|
|
ODT
44
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $19.5M | 0.55% |
708,038
-82,033
| -10% | -$2.26M |
|
|
BCEL
45
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $18.7M | 0.52% |
1,128,806
-8,000
| -0.7% | -$132K |
|
|
SWAV
46
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $18.5M | 0.52% |
557,800
-10,100
| -2% | -$335K |
|
47
Twist Bioscience
TWST
$1.58B
| $18M | 0.51% |
+590,200
| New | +$18M |
|
|
GRTS
48
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $17.9M | 0.5% |
3,068,194
-48,400
| -2% | -$282K |
|
|
HOOK
49
DELISTED
HOOKIPA Pharma
HOOK
| $15.4M | 0.43% |
1,862,510
-30,011
| -2% | -$248K |
|
|
TCRR
50
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $13.7M | 0.38% |
1,767,288
-31,900
| -2% | -$247K |
|